Filing Details
- Accession Number:
- 0001209191-20-030103
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-18 16:35:10
- Reporting Period:
- 2020-05-15
- Accepted Time:
- 2020-05-18 16:35:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1426332 | Ngm Biopharmaceuticals Inc | NGM | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1468482 | D Hsiao Lieu | 333 Oyster Point Boulevard South San Francisco CA 94080 | Svp, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-05-15 | 1,562 | $22.00 | 182 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Includes 182 shares purchased through the Issuer's employee stock purchase plan on May 15, 2020.
Billionaire Hedge Funds
